Compile Data Set for Download or QSAR
maximum 50k data
Found 288 Enz. Inhib. hit(s) with Target = 'Tyrosine-protein kinase ABL2'
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM50020310(CHEMBL3288854)
Affinity DataKi:  180nMAssay Description:Binding affinity to ARG (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM50331612(CHEMBL1290072 | N-(4-methoxybenzyl)benzofuro[2,3-b...)
Affinity DataKi: >1.00E+6nMAssay Description:Inhibition of human ABL2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM4552(4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-...)
Affinity DataIC50:  0.5nMAssay Description:Inhibition of ABL2More data for this Ligand-Target Pair
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM50427749(CHEMBL2324924)
Affinity DataIC50:  1nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM50427749(CHEMBL2324924)
Affinity DataIC50:  2nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM50427748(CHEMBL2324925)
Affinity DataIC50:  3nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM378885(US10266537, Compound 93)
Affinity DataIC50:  4nMAssay Description:The aim of this experiment is to detect the inhibitory activity of the compounds of the present invention against in vitro protein kinases using isot...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM378885(US10266537, Compound 93)
Affinity DataIC50:  4nMAssay Description:Inhibition of human recombinant ARG (38 to end residues) using EAIYAAPFAKKK as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM50427747(CHEMBL2324926)
Affinity DataIC50:  6nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM50427742(CHEMBL2324930)
Affinity DataIC50:  8nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM50427748(CHEMBL2324925)
Affinity DataIC50:  10nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM2579((2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-2...)
Affinity DataIC50:  10.1nMAssay Description:Inhibition of human ABL2 using EAIYAAPFAKKK as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM50427750(CHEMBL2324923)
Affinity DataIC50:  11nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM50427745(CHEMBL2324927)
Affinity DataIC50:  12nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM50427744(CHEMBL2324928)
Affinity DataIC50:  14nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM50427750(CHEMBL2324923)
Affinity DataIC50:  15nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM2579((2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-2...)
Affinity DataIC50:  15.8nMAssay Description:Inhibition of human ABL2 using EAIYAAPFAKKK as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM50427741(CHEMBL2324931)
Affinity DataIC50:  18nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM481113(US10906896, Cpd 117)
Affinity DataIC50:  35nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM612783(US11725005, Compound 117)
Affinity DataIC50:  35nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM50427743(CHEMBL2324929)
Affinity DataIC50:  36nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM481131(US10906896, Cpd 8300 | US10906896, Cpd 832 | US117...)
Affinity DataIC50:  39nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM612893(US11725005, Compound 8300)
Affinity DataIC50:  39nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM50427742(CHEMBL2324930)
Affinity DataIC50:  39nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM50427740(CHEMBL2324932)
Affinity DataIC50:  40nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM50427741(CHEMBL2324931)
Affinity DataIC50:  41nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM481115(US10906896, Cpd 119)
Affinity DataIC50:  44.7nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM612785(US11725005, Compound 119)
Affinity DataIC50:  44.7nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM50427747(CHEMBL2324926)
Affinity DataIC50:  47nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM612772(US11725005, Compound 113)
Affinity DataIC50:  50.1nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM481109(US10906896, Cpd 113)
Affinity DataIC50:  50.1nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM481130(US10906896, Cpd 830 | US11725005, Compound 830)
Affinity DataIC50:  51nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM612784(US11725005, Compound 118)
Affinity DataIC50:  51nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM481114(US10906896, Cpd 118)
Affinity DataIC50:  51nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM481130(US10906896, Cpd 830 | US11725005, Compound 830)
Affinity DataIC50:  51nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM50427744(CHEMBL2324928)
Affinity DataIC50:  66nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM481107(US10906896, Cpd 107)
Affinity DataIC50:  67nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM612764(US11725005, Compound 107)
Affinity DataIC50:  67nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM50427743(CHEMBL2324929)
Affinity DataIC50:  67nMAssay Description:Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM612791(US11725005, Compound 207)
Affinity DataIC50:  73.7nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM481119(US10906896, Cpd 207)
Affinity DataIC50:  73.7nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM2579((2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-2...)
Affinity DataIC50:  76nMAssay Description:Inhibition of ARG (unknown origin) incubated for 1 hr by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM481128(US10906896, Cpd 809 | US11725005, Compound 809)
Affinity DataIC50:  77nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM481131(US10906896, Cpd 8300 | US10906896, Cpd 832 | US117...)
Affinity DataIC50:  77nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM481131(US10906896, Cpd 8300 | US10906896, Cpd 832 | US117...)
Affinity DataIC50:  77nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM481128(US10906896, Cpd 809 | US11725005, Compound 809)
Affinity DataIC50:  77nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM481108(US10906896, Cpd 108)
Affinity DataIC50:  85.9nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM612767(US11725005, Compound 108)
Affinity DataIC50:  85.9nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM481137(US10906896, Cpd 8190 | US11725005, Compound 8190)
Affinity DataIC50:  91nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL2(Homo sapiens (Human))
Qilu Pharmaceutical Co.

Curated by ChEMBL
LigandPNGBDBM481137(US10906896, Cpd 8190 | US11725005, Compound 8190)
Affinity DataIC50:  91nMAssay Description:Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl22 mM DTT) and Stop buffer (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Reag...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 288 total ) | Next | Last >>
Jump to: